Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04145284 · ClinicalTrials.gov registry record

Quantitative Magnetic Resonance Imaging (MRI) Sub-Study of MS PATHS

A clinical trial of Multiple Sclerosis, sponsored by Biogen.

Completed
Registry status
6
Enrollment target
2
Study locations

NCT04145284 is a study of Multiple Sclerosis that has completed, run by Biogen. The registered enrollment target is 6 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04145284, a study of Multiple Sclerosis, has completed, sponsored by Biogen.

COMPLETED
Registry status
6 participants
Enrollment target
2
Study locations

Study Summary

The primary objective is to assess the performance of a new magnetic resonance imaging (MRI) metrics software prototype when used in radiological practice in multiple sclerosis (MS).

Conditions Studied

Multiple Sclerosis

Study Locations (2)

Ohio

  • Research Site - Cleveland

Saxony

  • Research Site - Dresden

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2019-04-30
Est. Completion 2020-04-30

Sponsor

Biogen

334 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04145284

The ClinicalTrials.gov registry entry for NCT04145284 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (99% lower). The listed sponsor is Biogen, which has 334 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 0 interventions.

NCT04145284 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Ohio, Saxony.

Frequently Asked Questions

What is clinical trial NCT04145284 about?

NCT04145284 is a clinical study titled "Quantitative Magnetic Resonance Imaging (MRI) Sub-Study of MS PATHS". The primary objective is to assess the performance of a new magnetic resonance imaging (MRI) metrics software prototype when used in radiological practice in multiple sclerosis (MS).

What is the current status of trial NCT04145284?

This trial is currently completed. The enrollment target is 6 participants. The study started on 2019-04-30. Estimated completion is 2020-04-30.

What conditions does trial NCT04145284 study?

This clinical trial studies the following conditions: Multiple Sclerosis.

Who is sponsoring clinical trial NCT04145284?

This trial is sponsored by Biogen, which has 334 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04145284 being conducted?

This trial has 2 study locations across Ohio, Saxony. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Multiple Sclerosis

All registered trials for this condition

Ohio

All trials with a study site in Ohio

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.